France Entertainment Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on France Entertainment Press.

Press releases published on July 7, 2026

Jul. 7, 2026

Dr. Timothy Adams Joins Bye Ol’ Dentistry Documentary on Biological Dentistry

Indeterminate EIN Presswire

Jul. 7, 2026

Business Reporter: Rethinking the role of people management

Indeterminate EIN Presswire

Jul. 7, 2026

Olorama révolutionne l'expérience cinématographique grâce à l'IA : il synchronise les parfums avec Avatar : Fire and Ash

Indeterminate EIN Presswire

Jul. 7, 2026

NewHold Investment Corp. III and newcleo Ltd. Announce Filing of Registration Statement on Form F-4 with the SEC in Connection With Proposed Business Combination

Indeterminate GlobeNewswire

Jul. 7, 2026

Visitor Registration Opens for AFRIDEX 2026 as Nigeria Prepares to Host Africa's Premier Defence and Security Exhibition

Indeterminate EIN Presswire

Jul. 7, 2026

Envu s’associe à Greencell pour lancer Fiata Boost, un biostimulant microbien déjà homologué sur trois marchés européens

Indeterminate EIN Presswire

Jul. 7, 2026

Diana Derval remporte le prix Insights Professional of the Year 2026

Indeterminate EIN Presswire

Jul. 7, 2026

ArtsPR has won 108 Awards/Selections for 5 Books and 2 Short Films on FilmFreeway in the last 5 years

Indeterminate EIN Presswire

Jul. 7, 2026

Ipsos announces the appointment of Claire Charbit as Head of CEO’s Office

Indeterminate GlobeNewswire

Jul. 7, 2026

Ipsos annonce la nomination de Claire Charbit au poste de Head of CEO’s Office

Indeterminate GlobeNewswire

Jul. 7, 2026

Pasqal and MegazoneCloud Partner to Bring Industrial-Scale Quantum Computing to South Korea

Indeterminate GlobeNewswire

Jul. 7, 2026

Cyllene Therapeutics (formerly known as EG 427) Raises €33 Million Series C Financing to Advance Clinical Development of EG110A and Pipeline Expansion

Indeterminate GlobeNewswire

Jul. 7, 2026

Cyllene Therapeutics (anciennement EG427) lève 33 millions d’euros lors d’une Série C pour accélérer le développement clinique d’EG110A et l’expansion de son pipeline

Indeterminate GlobeNewswire